OKMETIC WILL TRANSFER 18,540 OWN SHARES HELD BY THE COMPANY AS A PART OF THE COMPANY'S SHARE-BASED INCENTIVE SCHEME

OKMETIC OYJ STOCK EXCHANGE RELEASE    12 FEBRUARY 2013  AT 8.00 A.M. OKMETIC WILL TRANSFER 18,540 OWN SHARES HELD BY THE COMPANY AS A PART OF THE COMPANY'S SHARE-BASED INCENTIVE SCHEME Okmetic Oyj will transfer a total of 18,540 own shares held by the company as a part of the company's share-based incentive scheme for the executive management group, of which the company gave a stock exchange release on 8 February 2012. All the shares are issued to the members of the executive management group in deviation from the shareholders' pre-emptive rights (directed share issue). Okmetic's board of directors decided on 8 February 2012 on a performance-based share reward programme for the executive management group for 2012 as a part of the group's incentive and commitment scheme. Okmetic's board of directors has confirmed in its meeting on 11 February 2013 the remuneration that shall be granted for the earning period 1 January - 31 December 2012, based on the realisation of the targets set in the programme. The rewards of the share reward programme will be paid in Okmetic shares and in a monetary amount covering the taxes. The annual general meeting of Okmetic Oyj has on 12 April 2012 authorised the board of directors to transfer own shares held by the company for instance through a directed share issue. The company's board of directors has granted the persons participating in the share reward programme share rewards in accordance with the terms and conditions of the programme by means of a directed share issue without payment comprising a total of 18,540 own shares held by the company. The directed share issue without payment will be executed in full as there is no consideration related to the issue. The shares will entitle to shareholders' rights when the shares have been transferred to the shareholder. The share issue does not affect the share capital of the company. After the share issue, the company will hold 209,406 own shares. The shares earned based on the share reward programme must be held for at least two years after the reward disbursement. In addition, the president must hold at least half of the shares received as share reward for as long he is in the service of the company. If a person participating in the programme ceases to be in the service of the company, his rights based on the programme shall expire. The persons in the programme may change during the course of the programme. In addition to the share reward programme directed to the executive management group, Okmetic has a share ownership programme directed to the president and deputy to the president. OKMETIC OYJ Board of directors For further information, please contact: Senior Vice President, Finance, IT, and Communications Juha Jaatinen, Okmetic Oyj, tel. +358 9 5028 0286, email: juha.jaatinen@okmetic.com Distribution: NASDAQ OMX Helsinki Principal media www.okmetic.com OKMETIC IN BRIEF Take it higher Okmetic is a technology company which supplies tailor-made silicon wafers for sensor and semiconductor industries and sells its technological expertise to the solar cell industry. Okmetic provides its customers with solutions that boost their competitiveness and profitability. Okmetic's silicon wafers are part of a further processing chain that produces end products that improve human interaction and quality of life. Okmetic's products are based on high-tech expertise that generates added value for customers, innovative product development and an extremely efficient production process. Okmetic has a global customer base and sales network, production plants in Finland and the US and contract manufacturers in Japan and China. Okmetic's shares are listed on NASDAQ OMX Helsinki under the code OKM1V. For more information on the company, please visit our website at www.okmetic.com. OKME0613: http://hugin.info/132025/R/1677221/546889.pdf This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Okmetic Oyj via Thomson Reuters ONE [HUG#1677221]